BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Smorodin EP, Kurtenkov OA, Sergeyev BL, Kodar KE, Chuzmarov VI, Afanasyev VP. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: The follow-up study of gastrointestinal cancer patients. World J Gastroenterol 2008; 14(27): 4352-4358 [PMID: 18666325 DOI: 10.3748/wjg.14.4352]
URL: https://www.wjgnet.com/1007-9327/full/v14/i27/4352.htm
Number Citing Articles
1
Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, Anja Löffler, Jens Schmidt, Uwe Karsten, Michael Blaut, Steffen Goletz. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6Cancer Immunology, Immunotherapy 2013; 62(5): 875 doi: 10.1007/s00262-013-1394-x
2
Tatiana Pochechueva, Francis Jacob, Andre Fedier, Viola Heinzelmann-Schwarz. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput ApproachesMetabolites 2012; 2(4): 913 doi: 10.3390/metabo2040913
3
Behjatolah Monzavi-Karbassi, Anastas Pashov, Thomas Kieber-Emmons. Tumor-Associated Glycans and Immune SurveillanceVaccines 2013; 1(2): 174 doi: 10.3390/vaccines1020174
4
Anastas Pashov, Bejatolah Monzavi-Karbassi, Gajendra P. S. Raghava, Thomas Kieber-Emmons. Bridging Innate and Adaptive Antitumor Immunity Targeting GlycansJournal of Biomedicine and Biotechnology 2010; 2010: 1 doi: 10.1155/2010/354068
5
J. Sebastian Temme, Dorothy L. Butler, Jeffrey C. Gildersleeve. Anti-glycan antibodies: roles in human diseaseBiochemical Journal 2021; 478(8): 1485 doi: 10.1042/BCJ20200610
6
Oleg Kurtenkov, Kersti Klaamas. Increased Avidity of theSambucus nigraLectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric CancerDisease Markers 2015; 2015: 1 doi: 10.1155/2015/761908
7
Eugeniy P. Smorodin. Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal CancerInternational Journal of Molecular Sciences 2021; 22(21): 11608 doi: 10.3390/ijms222111608
8
Eugeniy P. Smorodin, Oleg A. Kurtenkov, Boris L. Sergeyev, Jelena S. Branovets, Jelena G. Izotova, Andrey A. Formanovsky. SPECIFICITY OF SERUM ANTI-AdiIgG ANTIBODIES FROM PATIENTS WITH GASTROINTESTINAL CANCERJournal of Immunoassay and Immunochemistry 2011; 32(3): 170 doi: 10.1080/15321819.2011.552584
9
Daniel Mazal, Richard Lo-Man, Sylvie Bay, Otto Pritsch, Edith Dériaud, Christelle Ganneau, Andrea Medeiros, Luis Ubillos, Gonzalo Obal, Nora Berois, Mariela Bollati-Fogolin, Claude Leclerc, Eduardo Osinaga. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancerCancer Immunology, Immunotherapy 2013; 62(6): 1107 doi: 10.1007/s00262-013-1425-7
10
Oleg Kurtenkov. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical PotentialBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9747040
11
Shih-Yun Guu, Tsung-Hsien Lin, Su-Chieh Chang, Rei-Jing Wang, Ling-Yi Hung, Po-Jan Fang, Wei-Chien Tang, Peiwen Yu, Chuan-Fa Chang, Gianpaolo Papaccio. Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patientsPLOS ONE 2017; 12(6): e0178927 doi: 10.1371/journal.pone.0178927
12
Marina M. Ziganshina, Nadezhda V. Shilova, Eugenia O. Khalturina, Natalya V. Dolgushina, Sergey V. Borisevich, Ekaterina L. Yarotskaya, Nicolai V. Bovin, Gennady T. Sukhikh. Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan AntibodiesViruses 2023; 15(7): 1584 doi: 10.3390/v15071584